In addition, E2F7 is highly expressed in HCC and colon cancer and can promote stemness in these cancers, suggesting that E2F7 may be a novel therapeutic target for HCC and colon cancer (23, 26). The gene discussed is E2F7; the disease is hepatocellular carcinoma.